CRBU Financial Statements | Balance Sheet, Income & Cash Flow Analysis
The financial statements for CRBU (CRBU) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| FHTX Foghorn Therapeutics Inc. | $4.87 +0.41% |
| R Ryder System, Inc. | $212.05 -3.54% |
| AARD Aardvark Therapeutics, Inc. Common Stock | $5.08 +9.48% |
| U Unity Software Inc. | $25.26 +8.18% |
| OBIO Orchestra BioMed Holdings, Inc. | $4.57 +1.33% |
| IVA Inventiva S.A. | $5.74 +4.17% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| FHTX Foghorn Therapeutics Inc. | $4.87 | +0.41% | 285.87 M | -4.13 | -1.18 | 0.00% | Buy | 137 |
| R Ryder System, Inc. | $212.05 | -3.54% | 8.36 B | 17.67 | 12.00 | 0.86% | Buy | 556 |
| AARD Aardvark Therapeutics, Inc. Common Stock | $5.08 | +9.48% | 110.83 M | -1.73 | -2.93 | 0.00% | Buy | 285 |
| U Unity Software Inc. | $25.26 | +8.18% | 10.94 B | -26.31 | -0.96 | 0.00% | Hold | 15.86 |
| OBIO Orchestra BioMed Holdings, Inc. | $4.57 | +1.33% | 267.44 M | -4.12 | -1.11 | 0.00% | Buy | 103 |
| IVA Inventiva S.A. | $5.74 | +4.17% | 298.38 M | -2.60 | -2.21 | 0.00% | Buy | 654 |
Frequently Asked Questions
What are CRBU's latest financial results?
Review CRBU's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has CRBU's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is CRBU's cash flow situation and liquidity?
Cash flow statements reveal how CRBU generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does CRBU's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether CRBU is outperforming or lagging within its sector.
Are CRBU's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether CRBU's profits are repeatable and supported by strong fundamentals.